CME: Pediatric and adolescent Crohn’s disease: therapeutic updates and optimizing medical and nutritional treatment
ACCREDITATION EXPIRED: March 12, 2026
Activity Description / Statement of Need:
In this online, self-learning activity:
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) defined by a transmural process that often occurs in the terminal ileum; although, any portion of the gastrointestinal (GI) tract can be affected. While the exact etiology of CD is unknown, a handful of genetic, immunologic, and environmental risk factors have been identified, including an impaired immune response to commensal or pathogenic intestinal microbiota that drives mucosal inflammation in genetically susceptible patients. About 34,000 children in the United States have CD, and the incidence of pediatric CD has increased by about 10% annually since 2007.
Target Audience:
HCPs including: pediatricians, pediatric gastroenterologists, and those whos pecialize in adolescent medicine; physician assistants, nurse practitioners, and pharmacists; and any other healthcare professionals with an interest in or who clinically encounter patients with pediatric CD.
Commercial Support Disclosure: This program is supported by an educational grant from Abbott Nutrition.
This activity is free of charge.
Release Date: March 12, 2024 -- Expiration Date: March 12, 2026
Faculty: Dinesh Pashankar, MD
Agenda
- Faculty Member Introduction and Disclosures
- Approach to the diagnosis and severity assessment of pediatric Crohn’s disease (CD)
- Nutritional and pharmacologictherapy of pediatric CD
- New and emerging therapies for pediatric CD
- Evaluation of a treatment plan for a specific pediatric patient with CD
- Concluding Remarks
Learning Objectives
By the end of the session the participant will be able to:
- Compare nutritional approaches to the induction and mainten ance of pediatric Crohn’s disease (CD).
- Identify approaches to the diagnosis and severity assessment of pediatric CD and apply them to patient cases using evidence - based medicine.
- Evaluate a treatment plan for a specific patient based on severity and presentation of pediatric CD to optimize safety and efficacy, suggesting modifications for improvement.
Accreditation
ACCME Activity #202621989
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.Faculty Disclosure and Resolution of COI
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Disclosure of Faculty: Dinesh S. Pashankar, MD, MBA, Director, Pediatric Inflammatory Bowel Disease Program, Yale University School of Medicine, has received financial compensation from Janssen and Abbvie for research support.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.
Faculty WILL discuss off-label uses of a commercial product.
All relevant financial relationships have been mitigated.
ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Commercial Support Disclosure: This program is supported by an educational grant from Abbott Nutrition.
Instructions
- Read the learning objectives above
- Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
- View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
- Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
- Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.
System Requirements
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Additional Courses That Are Related To This Activity
Taking the ‘pep’ out of H. pylori infection: updates in practice and treatment optimization